Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (14)

2024

  1. Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution

    eLife, Vol. 12

2022

  1. Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment

    British Journal of Haematology, Vol. 199, Núm. 5, pp. 754-764

  2. SimiC enables the inference of complex gene regulatory dynamics across cell phenotypes

    Communications Biology, Vol. 5, Núm. 1

  3. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma

    Leukemia, Vol. 35, Núm. 5, pp. 1438-1450

2019

  1. Genotyping and Sequencing

    Principles of Nutrigenetics and Nutrigenomics: Fundamentals of Individualized Nutrition (Elsevier), pp. 33-39

  2. NGS data analysis process

    Principles of Nutrigenetics and Nutrigenomics: Fundamentals of Individualized Nutrition (Elsevier), pp. 33-39

2018

  1. Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells

    Oncotarget, Vol. 9, Núm. 16, pp. 12842-12852

  2. The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer

    Laboratory Investigation, Vol. 98, Núm. 12, pp. 1562-1574

2012

  1. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

    Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1129-1136

2010

  1. Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

    BMC Genomics, Vol. 11, Núm. 1

  2. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression

    Clinical Cancer Research, Vol. 16, Núm. 16, pp. 4113-4125

2007

  1. Alternative splicing: an emerging topic in molecular and clinical oncology

    Lancet Oncology, Vol. 8, Núm. 4, pp. 349-357